Search

everythinglearnresearchcommunity

for

Search:↓

Combining CGF and microneedling with betamethasone effectively treats resistant alopecia areata.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Topical alpha-terthienyl with UVA may safely treat psoriasis without cancer risk.

Astragaloside A may help fight lung cancer by targeting specific proteins.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

Natural compounds may help treat advanced papillary thyroid cancer by targeting specific molecular pathways.

JAK inhibitors help treat some diseases but may increase risks of blood clots and cancer in certain patients.

New treatments for atopic dermatitis and alopecia areata have been developed using a targeted approach.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Combining low-dose dutasteride with finasteride improved a man's hair loss.

Tofacitinib effectively regrows hair in alopecia areata patients, especially in younger individuals, with manageable side effects.

Tofacitinib is effective and safe for elderly patients with ulcerative colitis.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

Imuvert can prevent some chemotherapy-induced hair loss.

Upadacitinib may effectively treat resistant lichen planopilaris.

Axitinib treatment turned a man's grey hair back to black.

Tofacitinib is a safe treatment for hair loss in children, but long-term use may be needed for best results.

COVID-19 affects patients on chemotherapy for gynecological cancer negatively.

Baicalin nanocapsules greatly enhance its anticancer effects on breast cancer cells.

S-1 treatment led to a complete response in pancreatic cancer with manageable side effects.

Tofacitinib may help treat severe hair loss, but more research is needed.

Methotrexate with corticosteroids can help regrow hair in severe alopecia areata but may cause relapses and side effects.

Adverse events from vismodegib can be managed effectively to ensure optimal treatment.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

The document concludes that biotin, folate, and RGD peptides are promising for targeting cancer cells with prodrugs, but the conjugates are not yet tested for use.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.